170 related articles for article (PubMed ID: 30584122)
1. Percutaneous irreversible electroporation of hepatocellular carcinoma: Contrast-enhanced ultrasound-findings during 1-year follow-up.
Niessen C; Beyer LP; Haimerl M; Schicho A; Stroszczynski C; Wiggermann P; Jung EM
Clin Hemorheol Microcirc; 2019; 72(1):85-93. PubMed ID: 30584122
[TBL] [Abstract][Full Text] [Related]
2. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous irreversible electroporation (IRE) of hepatic malignant tumours: contrast-enhanced ultrasound (CEUS) findings.
Wiggermann P; Zeman F; Niessen C; Agha A; Trabold B; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2012; 52(2-4):417-27. PubMed ID: 22986756
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous irreversible electroporation (IRE) of prostate cancer: Contrast-enhanced ultrasound (CEUS) findings during follow up.
Beyer LP; Pregler B; Nießen C; Michalik K; Haimerl M; Stroszczynski C; Jung EM; Wiggermann P
Clin Hemorheol Microcirc; 2016; 64(3):501-506. PubMed ID: 27935553
[TBL] [Abstract][Full Text] [Related]
5. Irreversible electroporation in patients with liver tumours: treated-area patterns with contrast-enhanced ultrasound.
Zhou L; Yin S; Chai W; Zhao Q; Tian G; Xu D; Jiang T
World J Surg Oncol; 2020 Nov; 18(1):305. PubMed ID: 33228665
[TBL] [Abstract][Full Text] [Related]
6. Color Coded Perfusion Imaging with Contrast Enhanced Ultrasound (CEUS) for Post-Interventional Success Control Following Irreversible Electroporation (IRE) of Primary and Secondary Malignant Liver Lesions.
Rennert J; Wiesinger I; Schicho A; Wiggermann P; Stroszczynski C; Beyer LP; Jung EM
J Gastrointestin Liver Dis; 2019 Sep; 28(3):311-318. PubMed ID: 31517328
[TBL] [Abstract][Full Text] [Related]
7. Comparison of computed tomography (CT) and contrast-enhanced ultrasound (CEUS) for the quantitative evaluation of an ablation defect following radiofrequency ablation of malignant liver lesions.
Bruenn K; Beyer L; Haimerl M; Pregler B; Stroszczynski C; Jung EM; Wiggermann P
Clin Hemorheol Microcirc; 2017; 67(3-4):445-451. PubMed ID: 28885212
[TBL] [Abstract][Full Text] [Related]
8. Irreversible Electroporation in Patients with Hepatocellular Carcinoma: Immediate versus Delayed Findings at MR Imaging.
Padia SA; Johnson GE; Yeung RS; Park JO; Hippe DS; Kogut MJ
Radiology; 2016 Jan; 278(1):285-94. PubMed ID: 26523493
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous irreversible electroporation (IRE) of prostate cancer: Contrast-enhanced ultrasound (CEUS) findings.
Niessen C; Jung EM; Beyer L; Pregler B; Dollinger M; Haimerl M; Scheer F; Stroszczynski C; Wiggermann P
Clin Hemorheol Microcirc; 2015; 61(2):135-41. PubMed ID: 26410867
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of integrated color-coded perfusion analysis for contrast-enhanced ultrasound (CEUS) after percutaneous interventions for malignant liver lesions: First results.
Wiesinger I; Beyer LP; Zausig N; Verloh N; Wiggermann P; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2018; 69(1-2):59-67. PubMed ID: 29758936
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound and Contrast-enhanced Ultrasound Findings after Percutaneous Irreversible Electroporation of Hepatic Malignant Tumors.
Chai W; Xie L; Zhao Q; Cheng C; Tian G; Jiang T; Wu P
Ultrasound Med Biol; 2020 Mar; 46(3):620-629. PubMed ID: 31924420
[TBL] [Abstract][Full Text] [Related]
12. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651
[TBL] [Abstract][Full Text] [Related]
13. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience.
Catalano O; Izzo F; Vallone P; Sandomenico F; Albino V; Nunziata A; Fusco R; Petrillo A
Acta Radiol; 2015 Feb; 56(2):133-42. PubMed ID: 24523360
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous Irreversible Electroporation (IRE) of Hepatic Malignancy: A Bi-institutional Analysis of Safety and Outcomes.
Mafeld S; Wong JJ; Kibriya N; Stenberg B; Manas D; Bassett P; Aslam T; Evans J; Littler P
Cardiovasc Intervent Radiol; 2019 Apr; 42(4):577-583. PubMed ID: 30465255
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic performance of contrast-enhanced ultrasound (CEUS) for evaluating hepatocellular carcinoma (HCC) juxtaposed to MRI findings; a retrospective single-center analysis of 292 patients.
Schwarze V; Marschner C; Völckers W; de Figueiredo GN; Rübenthaler J; Clevert DA
Clin Hemorheol Microcirc; 2020; 76(2):155-160. PubMed ID: 32925017
[TBL] [Abstract][Full Text] [Related]
16. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation.
Chen MH; Yang W; Yan K; Dai Y; Wu W; Fan ZH; Callstrom MR; Charboneau JW
Clin Radiol; 2007 Aug; 62(8):752-60. PubMed ID: 17604763
[TBL] [Abstract][Full Text] [Related]
17. Quantitative perfusion analysis of hepatocellular carcinoma using dynamic contrast enhanced ultrasound (CEUS) to determine tumor microvascularization.
Schaible J; Stroszczynski C; Beyer LP; Jung EM
Clin Hemorheol Microcirc; 2019; 73(1):95-104. PubMed ID: 31561349
[TBL] [Abstract][Full Text] [Related]
18. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
[No Abstract] [Full Text] [Related]
19. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
[TBL] [Abstract][Full Text] [Related]
20. MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy.
van den Bos W; de Bruin DM; van Randen A; Engelbrecht MR; Postema AW; Muller BG; Varkarakis IM; Skolarikos A; Savci-Heijink CD; Jurhill RR; Zondervan PJ; Laguna Pes MP; Wijkstra H; de Reijke TM; de la Rosette JJ
Eur Radiol; 2016 Jul; 26(7):2252-60. PubMed ID: 26449559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
